Anders Peter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anders Peter has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Hans Lilja
Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center , New York, NY
1 shared publication Johan Malm
Department of Laboratory Medicine, Section for Clinical Chemistry, Lund University, University Hospital, Malmö, Sweden
1 shared publication- Åke Lundwall
Department of Laboratory Medicine, Lund University, University Hospital, MAS, S-205 02 Malmö, Sweden
1 shared publication
Latest Publications
- Open Access
- 1 March 1998
- Published by Wiley in European Journal of Biochemistry
- Vol. 252 (2) , 216-221
Semenogelin I and semenogelin II, the major gel‐forming proteins in human semen, are substrates for transglutaminase
The major seminal vesicle secreted proteins in human semen, semenogelin I and semenogelin II, interact non‐covalently and via disulphide bridges to instantly form a coagulum upon ejaculation. The coagulum is liquefied after a few minutes due to the action of a prostatic serine protease, prostate‐specific antigen (PSA). In contrast to rat semen, which forms an insoluble plug within minutes of expulsion, no transglutaminase‐mediated cross‐linking has been demonstrated in ejaculated human semen. However, we here show that semenogelin I and semenogelin II, both in seminal vesicle fluid and purified from semen, are substrates for factor XIIIa, the fibrin cross‐linking transglutaminase. The cross‐linking of the semenogelins, which was conformation‐dependent, and the incorporation of a fluorescence‐labelled amine, were visualised by SDS/PAGE and Western blot. Purified semenogelin I and semenogelin II could be cross‐linked separately into complexes. Moreover, digestion of semenogelin with PSA produced fragments, some of which were cross‐linked into complexes by factor XIIIa. We also found that PSA was unable to release any semenogelin fragments during exposure of the high molecular‐mass complexes of cross‐linked semenogelin to active PSA.
- 1 March 1998
- Published by Wiley in European Journal of Biochemistry
- Vol. 252 (2) , 216-221
Open AccessSemenogelin I and semenogelin II, the major gel‐forming proteins in human semen, are substrates for transglutaminase
The major seminal vesicle secreted proteins in human semen, semenogelin I and semenogelin II, interact non‐covalently and via disulphide bridges to instantly form a coagulum upon ejaculation. The coagulum is liquefied after a few minutes due to the action of a prostatic serine protease, prostate‐specific antigen (PSA). In contrast to rat semen, which forms an insoluble plug within minutes of expulsion, no transglutaminase‐mediated cross‐linking has been demonstrated in ejaculated human semen. However, we here show that semenogelin I and semenogelin II, both in seminal vesicle fluid and purified from semen, are substrates for factor XIIIa, the fibrin cross‐linking transglutaminase. The cross‐linking of the semenogelins, which was conformation‐dependent, and the incorporation of a fluorescence‐labelled amine, were visualised by SDS/PAGE and Western blot. Purified semenogelin I and semenogelin II could be cross‐linked separately into complexes. Moreover, digestion of semenogelin with PSA produced fragments, some of which were cross‐linked into complexes by factor XIIIa. We also found that PSA was unable to release any semenogelin fragments during exposure of the high molecular‐mass complexes of cross‐linked semenogelin to active PSA.